(Q48414932)

11 February 2018

title

The MG-QOL15 Japanese version: validation and associations with clinical factors. (English)

1 reference

11 February 2018

4

Yuriko Nagane

1 reference

11 February 2018

2

Kimiaki Utsugisawa

1 reference

11 February 2018

3

Shigeaki Suzuki

1 reference

11 February 2018

Norihiro Suzuki

11

Norihiro Suzuki

1 reference

11 February 2018

Yasushi Suzuki

6

Yasushi Suzuki

1 reference

11 February 2018

Kazuo Fujihara

9

Kazuo Fujihara

1 reference

11 February 2018

Chiaki Kabasawa

5

Chiaki Kabasawa

1 reference

11 February 2018

Yuko Shimizu-Motohashi

7

Yuko Shimizu

1 reference

11 February 2018

Hiroya Utsumi

8

Hiroya Utsumi

1 reference

11 February 2018

Shinichiro Uchiyama

10

Shinichiro Uchiyama

1 reference

11 February 2018

author name string

Masayuki Masuda

1

1 reference

11 February 2018

publication date

1 August 2012

1 reference

11 February 2018

published in

Muscle and Nerve

1 reference

11 February 2018

volume

46

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

166-173

1 reference

11 February 2018

Autoimmune myasthenia gravis

cites work

1 reference

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

21 January 2018

1 reference

Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment

21 January 2018

1 reference

Lifetime course of myasthenia gravis

21 January 2018

1 reference

21 January 2018

1 reference

Quality of life and well-being of patients with myasthenia gravis.

21 January 2018

1 reference

History of outcome measures for myasthenia gravis

21 January 2018

1 reference

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

Disease-specific measure of quality of life for myasthenia gravis

21 January 2018

1 reference

Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis

21 January 2018

1 reference

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

21 January 2018

1 reference

Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan

21 January 2018

1 reference

Cross-cultural validation of the Beck Depression Inventory-II in Japan

21 January 2018

1 reference

Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite

21 January 2018

1 reference

The MG Composite: A valid and reliable outcome measure for myasthenia gravis

21 January 2018

1 reference

Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines

21 January 2018

1 reference

Guidelines for the process of cross-cultural adaptation of self-report measures

21 January 2018

1 reference

Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study

21 January 2018

1 reference

Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients

21 January 2018

1 reference

Early aggressive treatment strategy against myasthenia gravis

21 January 2018

1 reference

Quality of life and life circumstances in German myasthenia gravis patients

21 January 2018

1 reference

Classification of Myasthenia Gravis Based on Autoantibody Status

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.23398

1 reference

11 February 2018

PubMed ID

22806364

1 reference

11 February 2018